EARLY PDD CYSTOSCOPY AFTER BCG INDUCTION INCREASES DETECTION OF BCG-REFRACTORY TUMORS

被引：0
|
作者：
Morelli, Michele [1 ]
Baboudjian, Michael [1 ]
Tadrist, Abel [1 ]
Gondran-tellier, Bastien [1 ]
Karsenty, Gilles [1 ]
Lechevallier, Eric [1 ]
Montanari, Emanuele [2 ]
Boissier, Romain [1 ]
机构：
[1] Conception Hosp, AP HM, Dept Urol & Kidney Transplantat, Marseilles, France
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Urol, Milan, Italy
来源：
ANTICANCER RESEARCH | 2021年 / 41卷 / 10期
关键词：
D O I：
10.21873/anticanres.15345
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1
引用
下载
收藏
页码：5259 / 5259
页数：1
相关论文
共 50 条
  • [31] INDUCTION OF ICAM-1 EXPRESSION ON BLADDER-TUMORS BY BCG IMMUNOTHERAPY
    JACKSON, AM
    ALEXANDROFF, AB
    MCINTYRE, M
    ESUVARANATHAN, K
    JAMES, K
    CHISHOLM, GD
    JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (04) : 309 - 312
  • [32] CLINICAL OUTCOMES OF A RANDOMIZED, PROSPECTIVE, PHASE II STUDY TO DETERMINE THE EFFICACY OF BACILLUS CALMETTE-GUERIN (BCG) GIVEN IN COMBINATION WITH PANVAC VERSUS BCG GIVEN ALONE IN ADULTS WITH HIGH GRADE BCG-REFRACTORY NON-MUSCLE INVASIVE BLADDER CANCER
    Saoud, Ragheed
    Telfer, Siobhan
    Maruf, Mahir
    Singer, Eric
    Weiss, Robert
    Jang, Thomas
    Elsamra, Sammy
    Marino, Maria
    Valera, Vladimir
    Rodriguez, Beatriz Walter
    Railkar, Reema
    Dolan, Rebecca
    Bellfield, Sonia
    Stamatakis, Lambros
    Shih, Joanna
    Brancato, Sam
    Donohue, Renee
    Pico Navarro, Cesar
    Apolo, Andrea
    Gulley, James
    Schlom, Jeffrey
    Agarwal, Piyush
    JOURNAL OF UROLOGY, 2021, 206 : E302 - E302
  • [33] Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer
    Zahoor, Haris
    Mir, Maria C.
    Barata, Pedro C.
    Stephenson, Andrew J.
    Campbell, Steven C.
    Fergany, Amr
    Dreicer, Robert
    Garcia, Jorge A.
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (06) : 1231 - 1238
  • [34] BCG strain S4-Jena: An early BCG strain is capable to reduce the proliferation of bladder cancer cells by induction of apoptosis
    Katja Schwarzer
    Martin Foerster
    Thomas Steiner
    Inge-Marie Hermann
    Eberhard Straube
    Cancer Cell International, 10
  • [35] BCG strain S4-Jena: An early BCG strain is capable to reduce the proliferation of bladder cancer cells by induction of apoptosis
    Schwarzer, Katja
    Foerster, Martin
    Steiner, Thomas
    Hermann, Inge-Marie
    Straube, Eberhard
    CANCER CELL INTERNATIONAL, 2010, 10
  • [36] A PHASE II/III TRIAL OF CG0070, AN ONCOLYTIC ADENOVIRUS, FOR BCG-REFRACTORY NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC)
    Packiam, Vignesh T.
    Campanile, Alexa N.
    Barocas, Daniel A.
    Chamie, Karim
    Davis, Ronald L., III
    Kader, A. Karim
    Lamm, Donald L.
    Yeung, Alex W.
    Steinberg, Gary D.
    JOURNAL OF UROLOGY, 2016, 195 (04): : E142 - E142
  • [37] DETECTION OF INTERLEUKIN-2 IN THE URINE OF PATIENTS WITH SUPERFICIAL BLADDER-TUMORS AFTER TREATMENT WITH INTRAVESICAL BCG
    HAAFF, EO
    CATALONA, WJ
    RATLIFF, TL
    JOURNAL OF UROLOGY, 1986, 136 (04): : 970 - 974
  • [38] DETECTION OF INTERLEUKIN-2 IN THE URINE OF PATIENTS WITH SUPERFICIAL BLADDER-TUMORS AFTER TREATMENT WITH INTRAVESICAL BCG
    HAAFF, EO
    RATLIFF, TL
    JOURNAL OF UROLOGY, 1986, 135 (04): : A245 - A245
  • [39] Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer
    Haris Zahoor
    Maria C. Mir
    Pedro C. Barata
    Andrew J. Stephenson
    Steven C. Campbell
    Amr Fergany
    Robert Dreicer
    Jorge A. Garcia
    Investigational New Drugs, 2019, 37 : 1231 - 1238
  • [40] A phase I trial for the use of intravesical cabazitaxel, gemcitabine, and cisplatin (CGC) in the treatment of BCG-refractory nonmuscle invasive urothelial carcinoma of the bladder.
    DeCastro, Guarionex Joel
    Sui, Wilson
    Pak, Jamie S.
    Abate-Shen, Corinne T.
    Lee, Shing Mirn
    Anderson, Christopher B.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
12345